A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...

Get real-time updates on health from celebrity fitness secrets and weight loss breakthroughs to nutrition advice, get your ...

Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...

Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Novo Nordisk ( NVO -2.98%) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, ...

An asteroid becomes a meteorite when it travels to Earth from a nearby orbit or the outer solar system and collides with ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.